MetLife Investment Management’s Organon & Co OGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.5K	Buy	4,257 +7	+0.2%	+$53	﹤0.01%	2728
2025 Q4	$30.5K	Sell	4,250 -80	-2%	-$632	﹤0.01%	2761
2025 Q3	$46.2K	Buy	4,330 +4	+0.1%	+$39	﹤0.01%	2799
2025 Q2	$41.9K	Sell	4,326 -299	-6%	-$3.08K	﹤0.01%	2692
2025 Q1	$68.9K	Buy	4,625 +106	+2%	+$1.63K	﹤0.01%	2651
2024 Q4	$67.4K	Buy	4,519 +13	+0.3%	+$212	﹤0.01%	2711
2024 Q3	$86.2K	Sell	4,506 -102	-2%	-$2.11K	﹤0.01%	2682
2024 Q2	$95.4K	Sell	4,608 -374	-8%	-$7.43K	﹤0.01%	2630
2024 Q1	$93.7K	Buy	4,982 +12	+0.2%	+$206	﹤0.01%	2565
2023 Q4	$71.7K	Sell	4,970 -58,236	-92%	-$792K	﹤0.01%	2732
2023 Q3	$1.1M	Sell	63,206 -1,534	-2%	-$32K	0.01%	1181
2023 Q2	$1.35M	Sell	64,740 -893	-1%	-$19.4K	0.01%	1109
2023 Q1	$1.54M	Sell	65,633 -788	-1%	-$21.2K	0.01%	1010
2022 Q4	$1.86M	Sell	66,421 -1,077	-2%	-$27.5K	0.01%	935
2022 Q3	$1.58M	Sell	67,498 -836	-1%	-$25.2K	0.01%	980
2022 Q2	$2.31M	Sell	68,334 -653	-0.9%	-$22.9K	0.02%	846
2022 Q1	$2.41M	Buy	68,987 +12,969	+23%	+$444K	0.02%	923
2021 Q4	$1.71M	Sell	56,018 -1,241	-2%	-$40.4K	0.01%	923
2021 Q3	$1.88M	Sell	57,259 -1,404	-2%	-$44.9K	0.02%	884
2021 Q2	$1.78M	Buy	+58,663	New	+$1.93M	0.02%	923